Stage redistribution and survival among Medicare beneficiaries before and after the approval of positron emission tomography scan for non-Hodgkin lymphoma

Leukemia and Lymphoma

Volumn 56, Issue 5, 2015, Pages 1544-1546

  Al Hamadani, Mohammed ^a   Go, Ronald S ^b  

^a GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; HUMAN; LETTER; MEDICARE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; LYMPHOMA, NON-HODGKIN; MORTALITY; PROGNOSIS; UNITED STATES;

HUMANS; LYMPHOMA, NON-HODGKIN; MEDICARE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; UNITED STATES;

EID: 84932136234     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.966709     Document Type: Letter

References (17)

1. Centers for Medicare & Medicaid Services [Internet]. National coverage determination for positron emission tomography (PET) scans (220.6). Available from: http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId = 211&ncdver = 4&NCAId = 92&ver = 19&NcaName = Positron+ Emission-I-Tomography+ &bc = BEAAAAAAIAAA&
2. Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA 2012;307:2400-2409.
3. Chee KG, Nguyen DV, Brown M, et al. Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited. Arch Intern Med 2008; 168: 1541-1549.
4. Misono S, Rue T, Rajendran J, et al. Effects of upstaging from PET scan on survival in head and neck squamous cell carcinoma. Head Neck 2010;32:1283-1287.
5. Risum S, Hogdall C, Loft A, et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gyn Oncol 2010; 116: 395-398.
6. Dinan MA, Curtis LH, Carpenter WR, et al. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among Medicare benef ciaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol 2012;30:2725-2730.
7. National Cancer Data Base [Internet]. Available from: http://www. facs.org/cancer/ncdb/
8. US Food and Drug Administration [Internet]. Available from: http://www.fda.gov/default.htm
9. Swenson WT, Wooldridge JE, Lynch CF, et al. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005;23:5019-5026.
10. Flowers CR, Fedewa SA, Chen AY, et al. Disparities in the early adoption of chemoimmunotherapy for dif use large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev 2012; 21: 1520-1530.
11. Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: f rst report of the national LymphoCare study. J Clin Oncol 2009;27:1202-1208.
12. Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007; 110: 3507-3516.
13. Khan AB, Barrington SF, Mikhaeel NG, et al. PET-CT staging of DLBCL accurately identif es and provides new insight into the clinical signifcance of bone marrow involvement. Blood 2013;122: 61-67.
14. Centers for Medicare & Medicaid Services [Internet]. National coverage determination for stem cell transplantation (110.8.1). Available from: http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId = 45&ncdver = 5&NCAId = 10&ver = 8&NcaName = Autologous-I-Stem+ Cell+Transplantation+(AuSCT)+ for+ Multiple + Myeloma&bc = ACAAAAAAIAAA&
15. Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis dif use large-B-cell lymphoma: a randomized controlled trial by the MabT era International Trial (MInT) Group. Lancet Oncol 2006; 7: 379-391.
16. Hofman MS, Ball DL, Mac Manus MP. Let's get SEERious: more accurate staging with consequent high management impact is not just stage migration. J Clin Oncol 2013; 31: 819.
17. Olszewski AJ, Castillo JJ. Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database. Ann Oncol 2013; 24: 1352-1359.